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What are the reproductive and developmental risks of in utero exposure 
to ionizing radiation? 
1 Birth defects, mental retardation and other neurobehavioral effects, 
growth retardation and embryonic death are deterministic effects 
(threshold effects). This indicates that these effects have a NOAEL (no 
adverse effect level). Almost all diagnostic radiological procedures pro­
vide exposures that are below the NOAEL for these developmental 
effects. Diagnostic radiological studies rarely exceed 10 rad (0.1 Gy), 
while the threshold for congenital malformations or miscarriage is >20 
rad (0.2 Gy) (Table 3.1). 
2 	In order for the embryo to be deleteriously affected by ionizing radi­
ation when the mother is exposed to a diagnostic study, the embryo 
has to be exposed above the NOAEL to increase the risk of determin­
istic effects. This rarely happens when pregnant women undergo x-ray 
studies of the head, neck, chest or extremities. 
3 During the pre-implantation and pre-organogenesis stages of embry­
onic development the embryo is least likely to be malformed by the 
effects of ionizing radiation because the cells of the very young embryo 
are omnipotential and can replace adjacent cells that have been delete­
riously affected. This early period of development has been designated 
as the 'all or none' period. 
4 Protraction and fractionation of exposures of ionizing radiation to the 
embryo decrease the magnitude of the deleterious effects of determin­
istic effects. 
5 The increased risk of cancer following high exposures to ionizing radi­
ation exposure to adult populations has been demonstrated in the 
atomic bomb survivor population. Radiation-induced carcinogenesis is 
assumed to be a stochastic effect (non-threshold effect) so that there 
is theoretically a risk at low exposures. While there is no question that 
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Table 3.1 Radiation exposure and risk at different gestational phases. There is no 
evidence that radiation exposure in the diagnostic ranges «0.10 Gy, <10 rad) is 
associated with measurably increased incidence of congenital malfonnation, stillbirth, 
miscarriage, growth and mental retardation 
Stage, gestation weeks Effect 
1 st and 2nd weeks after 1 st day of the 
last menstrual period (LMP) (prior to 
conception) 
3rd and 4th week of gestation (first 2 
weeks post conception) 
4th to 8th week of gestation (2nd to 
6th week post conception) 
8th to 15th week of gestation 
16th week of gestation to term 
First 2 weeks after 1st day of the last menstrual 
period. This is a preconception radiation 
exposure. Mother has not yet ovulated 
Minimum human acute lethal dose (from 
animal studies) approx 0.15-0.20 Gy. Most 
sensitive period for the induction of embryonic 
death 
Minimum lethal dose (from animal studies) at 
18 days post conception = 0.25 Gy (25 rad); 
after 50 days post conception >0.50 Gy 
(50 radIo 
Embryo is predisposed to the induction of 
major malformations and growth retardation, 
Minimum dose for growth retardation: at 
18-36 days 0.20-0.50 Gy (20-50 rad) 
and at 36-110 days = 0.25-0.5 Gy (25-50 rad), 
But the induced growth retardation during 
this period is not as severe as during 
mid-gestation from similar exposures 
Most vulnerable period for irreversible 
whole body growth retardation, 
microcephaly and severe mental 
retardation. Threshold for severe metal 
retardation is 0.35-0.50 Gy (35-50 rad).' 
Miller2 indicated that the threshold was 
>50 rad (1999). Decrease in 10 may 
occur at lower exposures but is difficult to 
document, There is probably no 
increased risk for mental retardation with 
eXPQsures <0,10 Gy 
Higher exposures can produce growth 
retardation and decreased brain size 
and intellect, although the effects are 
not as severe as what occurs from 
similar exposures during mid-gestation. 
There is no risk for major anatomical 
malformations. The threshold dose for 
lethality (from animal studies) from 
15 weeks to term is > 1.5 Gy (150 rad), 
Minimum dose for severe mental retardation: 
at 1 5 weeks to term = > 1 ,50 Gy, but decrease 
in 10 can occur at lower exposures 
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high exposures of ionizing radiation can increase the risk of cancer, the 
magnitude of the risk of cancer from embryonic exposures following 
diagnostic radiological procedures is very controversial. Recent publi­
cations and analyses indicate that the risk is lower for the irradiated 
embryo than for the irradiated child, which surprised many scientists 
interested in this subject. 
Evaluating the risks 
The responsibility for evaluating risks of environmental toxicants to the 
pregnant patient and her embryo frequently lies with the obstetrician. 
When evaluating the risks of ionizing radiation, the physician is faced 
with several different clinical situations, as outlined below. 
1 The pregnant patient presents with clinical symptoms that need to be 
evaluated. What is the appropriate utilization of diagnostic radiological 
procedures that may expose the embryo or fetus to ionizing radiation? 
A pregnant or possibly pregnant woman complaining of gastrointes­
tinal bleeding, abdominal or back pain, or an abdominal or pelvic mass 
that cannot be attributed to pregnancy deserves the appropriate studies 
to diagnose and treat her clinical problems, including radiological studies. 
Furthermore, these studies should not be relegated to one portion of the 
menstrual cycle if she has not yet missed her period. The studies should 
be performed at the time they are clinically indicated whether or not the 
woman is in the first or second half of the menstrual cycle. 
2 The patient has completed a diagnostic procedure that has exposed her 
uterus to ionizing radiation. Her pregnancy test was negative. She now 

believes she was pregnant at the time of the procedure. What is your 

response to this situation? 

Explain that you would have proceeded with the necessary x-ray diag­

nostic test whether she was pregnant or not, since diagnostic studies that 
are indicated in the mother have to take priority over the possible risk to 
her embryo, because almost 100% of diagnostic studies do not increase the 
risks to the embryo (Table 3.1). Second, she must have been very early in 
her pregnancy, since her pregnancy test was negative. At this time, obtain 
the calculated dose to the embryo and determine her stage of pregnancy. H 
the dose is below 10 rad (0.1 Gy, 0.1 Sv), you can inform the mother that 
her risks for birth defects and miscarriage have not been increased. In fact 
the threshold for these effects is 20 rad (0.2 Gy) at the most sensitive stage 
of embryonic development (Tables 3.1 and 3.2). Of course, you are obli­
gated to tell her that every healthy woman is at risk for the background 
incidence of birth defects and miscarriage, which is 3% for birth defects 
and 15% for miscarriage. Every woman faces these risks. 
~--------~ -~-~~~-----------
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Table 3.2 Risk of 5 rad (5 rem, 50 mSv, 5000 mrem) to embryo 
Risk Orad exposure Additional risk of 
5 rad exposure 
Risk of very early pregnancy loss, 
before the first missed period 
Risk of spontaneous abortion in 
known pregnant women 
Risk of major congenital 
malformations 
Risk of severe mental retardation 
Risk of childhood leukemiafyear 
Risk of early- or late-onset 
genetic disease 
Prematurity 
Growth retardation 
Stillbirth 
Infertility 
350,0001106 pregnancies 
150,0001106 pregnancies 
5000/106 
4011 Q6/year 
100,000/106 
(5.6% to 12.4%) 60,0001106 
30,000/106 pregnancies 
20-200011 06 pregnancies 
7% of couples 
o 
o 
o 
o 
<21106/year 
Very low risk is in next 
generation and is not 
measurable increased 
with small populations 
o 
o 
o 
o 
3 A woman delivers a baby with serious birth defects. On her first 
postpartum visit, she recalls that she had a diagnostic x-ray study early 
in her pregnancy. What is your response when she asks you whether 
the baby's malformation could be caused by the radiation exposure? 
In most instances, the nature of the clinical malformations will rule out 
radiation teratogenesis. At this time, a clinical teratologist or radiation 
embryologist could be of assistance. On the other hand, if the exposure is 
below 10 rad (0.1 Gy), it would not be scientifically supportable to indi­
cate that the radiation exposure was the cause of the malformation. As 
mentioned before, the threshold for malformations is 20 rad (0.20 Gy). 
Dose, timing, and the nature of the malformation would enter into this 
analysis. 
In order to appropriately and more completely respond to these ques­
tions, the obstetrician should rely on the extensive amount of information 
that has accumulated on the effects of radiation on the embryo. In fact, 
there is no environmental hazard that has been more extensively studied 
or on which more information is available. 1-9 (See Tables 3.1 and 3.2.) 
Radiation risks to the embryo 
There is no question that an acute exposure to ionizing radiation above 
50 rad represents a significant risk to the embryo, regardless of the stage 
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of gestation.6-11 The threshold dose for low LET (low energy transfer) 
ionizing radiation that results in an increase in malformations is approxi­
•
mately 20 rad (0.2 Gy) (Table 3.1). Although congenital malformations 
are unlikely to be produced by radiation during the first 14 days of 
human development, there would be a substantial risk of embryonic 
loss if the dose is high. From approximately the 18th day to the 40th day 
post-conception, the embryo would be at risk for an increased frequency 
of anatomical malformations if the embryonic exposure is greater than 
20-25 rad (0.2-0.25 Gy). Up until about the 15th week, the embryo main­
tains an increased susceptibility to central nervous system (CNS) effects, 
major CNS malformations early in gestation, and mental retardation 
in mid-gestation. Of course, with very high doses, in the 100s of rads, 
mental retardation can be produced in the latter part of gestation. While 
it is true that the embryo is sensitive to the deleterious effects of these 
mid-range exposures of ionizing radiation, the measurable effects falloff 
rapidly as the exposure approaches the usual exposures that the embryo 
receives from diagnostic radiological procedures «10 rad; 0.1 Gy). The 
threshold of 20 rad at the most sensitive stage of development (20-25 
days post-conception) is raised by protraction of the radiation exposure, 
for example, following several clinical diagnostic radiological procedures 
occurring over a period of days.6,lO,11 
That is why the recommendation of most official organizations, includ­
ing the National Council on Radiation Protection and Measurements 
(NCRP),6,8.9 indicates that exposures in the diagnostic range will not 
increase the risk of birth defects or miscarriage. The risks of radiation 
exposure to the human embryo when the exposure exceeds the no-effect 
dose (20 rad) are: 
• embryonic loss 
• growth retardation 
• congenital malformations 
• carcinogenesis (the magnitude of the risk is controversial)6 
• microcephaly and mental retardation 
• sterility. 
Because all of the above effects are threshold phenomena, except for car­
cinogenesis, radiation exposure below 10 rad (0.1 Gy) literally presents 
no measurable risk to the embryo. Even if one accepts the controversial 
concept that the embryo is more sensitive to the carcinogenic effects of 
radiation than the child, the risk at these low exposures is much smaller 
that the spontaneous risks.3 Furthermore, other studies indicate that 
Stewart's12 estimate of the risk involved is exaggerated.l3--15 
'DIble 3.2 compares the spontaneous risks facing an embryo at concep­
tion and the risks from a low exposure of ionizing radiation (5 rad, 50 mGy, 
5000mrad). 
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Therefore, the hazards of exposures in the range of diagnostic roent­
genology (2000-10,000 mrad; 0.02-0.1 Gy) (0.2 mGy-O.l Gy) present an 
extremely low risk to the embryo, when compared with the spontane­
ous mishaps that can befall human embryos (Table 3.2). Approximately 
30-40% of human embryos abort spontaneously (many abort before the 
first missed menstrual period). Human infants have a 2.75% major mal­
formation rate at term; which rises to approximately 6-10% once all mal­
formations become manifest. In spite of the fact that doses of 1-3 rad can 
produce cellular effects and the fact that diagnostic exposure during preg­
nancy has been associated with malignancy in childhood, the maximum 
theoretical risk to human embryos exposed to doses of 10 rad or less is 
extremely small. When the data and risks are explained to the patient, the 
family with a wanted pregnancy invariably continues with the pregnancy. 
The difficulty that frequently arises is that the risks from diagnostic 
radiation are evaluated outside the context of the significant normal risks 
of pregnancy. Furthermore, many physicians approach the evaluation 
of diagnostic radiation exposure with either of two extremes: a cavalier 
attitude or panic. The usual procedures in clinical medicine are ignored, 
and an opinion based on meager information is given to the patient. 
Frequently, it reflects the physician's bias about radiation effects or his or 
her ignorance of the field of radiation biology. We have records in our 
files of scores of patients who were not properly evaluated but were 
advised to have an abortion following radiation exposure. The following 
case history is a typical example. 
Case report 
A 27-year-old woman (gravida 3, pars 2, abortus 0) called on a Friday 
afternoon because she was 8 weeks pregnant and was scheduled for a 
therapeutic abortion on Monday morning. Her obstetrician and a pediatric 
genetic counselor had advised her to have a therapeutic abortion because 
at the time of conception she had had several x-ray examinations of the 
abdomen, and they were concerned that the embryo would be malformed. 
Dosimetry had not been performed, and an evaluation had not been ini­
tiated. It took about 10 minutes on the telephone to determine that she 
became pregnant after the diagnostic radiation studies had been completed 
and that her two previous boys had developmental problems (hemangi­
oma and pyloric stenosis). She canceled the abortion, and she delivered 
a normal full-term girl. She was adequately warned that we could not 
guarantee the outcome of the pregnancy - that there are 27.5 serious mal­
formations per 1000 births as a minimum. She had another determining 
factor in that she had a serious problem with varicose veins and planned 
Ionizing Radiation 27 
a tubal ligation after either the abortion or the delivery. This case history 
illustrates the inadequate amount of data that was collected by the phy­
sicians before counseling the patient. There was an added feature in this 
case. The paternal family was religiously devout and the consideration of 
an abortion was causing much dissension within the family. 
Evaluating the patient 
Case histories similar to this are transmitted to our laboratory frequently. 
In most instances, the dose to the embryo is <10 rad (0.1 Gy) and fre­
quently is <1 rad (0.01 Gy). Our experience has taught us that there are 
many variables involved in radiation exposure to a pregnant or poten­
tially pregnant woman. Therefore, there is no routine or predetermined 
advice that can be given in this situation. However, if the physician takes 
a systematic approach to the evaluation of the possible effects of radiation 
exposure, he/she can help the patient make an informed decision about 
continuing the pregnancy. This systematic evaluation can begin only 
when the following information has been obtained; 
• stage of pregnancy at the time of exposure 
• menstrual history 
• previous pregnancy history 
• family history of congenital malformations 
• other potentially harmful environmental factors during the pregnancy 
• ages of the mother and father 
• type of radiation study, dates and number of studies performed 
• calculation of the embryonic exposure by a medical physicist or compe­
tent radiologist 
• status of the pregnancy: wanted or unwanted. 
An evaluation should be made of the information, with both patient and 
counselor arriving at a decision. The physician should place a summary of 
the following information in the medical record. It should state that the 
patient has been informed that every pregnancy has a significant risk of 
problems and that the decision to continue the pregnancy does not mean 
that the counselor is guaranteeing the outcome of the pregnancy. The 
use of amniocentesis and ultrasound to evaluate the fetus is an individual 
decision that would have to be made in each pregnancy. 
The carcinogenic effects of radiation 
The carcinogenic risk of in utero radiation is an important topic that can­
not be addressed adequately in this publication. Alice Stewart12 published 
the results of her case-control study indicating the diagnostic radiation from 
pelvimetry increased the risk of childhood leukemia by 50% (Table 3.2). 
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Table 3.3 Follow-up of adults with solid cancers in Hiroshirila and Nagasaki who were 
in utero at the time of detonation of the A-bombs in 1945 (Preston et al. 2008) 
Dose in Sv (rads) No. of No. of Person-years % with solid 
patients cancers cancers 
<0.005 «0.5) 1547 54 49.326 3.5 
0.005-<0.1 (0.5-10) 435 16 14.005 3.7 
0.1-<0.2 (10--<20) 168 6 5041 3.6 
0.2-<0.5 (20--<50) 172 8 5496 4.6 
0.5-<1.0 (50--<100) 92 7 2771 7.6 
>1.0 48 3 1404 6.2 
Total 2452 94 94 3.5 
Table 3.4 Follow-up of adults with solid cancers in Hiroshima and Nagasaki who were 
in children at the time of detonation of the A-bombs in 1945 (Preston et al. 2008) 
Dose in Sv (rads) No. of No. of Person-years % of cancers 
patients cancers 
<0.005 «0.5) 8549 318 247,744 3.7 
0.005-<0.1 (0.5-<10) 4528 173 134,621 3.8 
0.1-<0.2 (10--<20) 853 38 25,802 4.4 
0.2-<0.5 (20--<50) 859 51 25,722 5.9 
0.5-<1.0 (50--<100) 325 21 9522 6.5 
>1.0 274 48 7620 17.5 
Total 15.388 649 451,031 4.2 
That would change the annual risk of childhood leukemia from 4 cases 
per 100,000 children to 6 cases per 100,000 children in the population of 
exposed fetuses. This has been a very controversial subject. 10--15 A recent 
publication by Preston et al.16 presented data from the in utero population 
of the A-bomb survivors which indicated that the embryo was less vulner­
able to the oncogenic effects of ionizing radiation than the child. It appears 
that the embryo is much less vulnerable to the oncogenic effects of radiation 
than previous investigators have believed. Patients can be told that the fetal 
risks are extremely small, so small that we cannot measure the risks because 
such a large exposed population would be necessary (Tables 3.3 and 3.4). 
Diagnostic or therapeutic abdominal radiation 
in women of reprodudive age 
Inwomen of reproductive age, it is important for the patient and physidan 
to be aware of the pregnancy status of the patient before performing any 
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type of x-ray procedure in which the ovaries or uterus will be exposed. 
If the embryonic exposure will be 10 rad or less, the radiation risks to 
the embryo are very small when compared with the spontaneous risks 
(Table 3.2). Even if the exposure is 10 rad, this exposure is far from the 
threshold or no-effect dose of 20 rad. The patient will accept this informa­
tion if it is offered as part of the preparation for the x-ray studies at a time 
when both the physician and patient are aware that a pregnancy exists 
or may exist. The pregnancy status of the patient should be determined 
and noted. 
Because the risks of 10 rad fetal irradiation are so small. the immediate 
medical care of the mother should take priority over the risks of diag­
nostic radiation exposure to the embryo. X-ray studies that are essential 
for optimal medical care of the mother and evaluation of medical prob­
lems that need to be diagnosed or treated should not be postponed. 
Elective procedures such as employment examinations or follow-up 
examinations. once a diagnosis has been made. need not be performed 
on a pregnant woman even though the risk to the embryo is very small. 
If other procedures (e.g., MRI or ultrasound) can provide adequate 
information without exposing the embryo to ionizing radiation. then 
of course they should be used. Naturally, there is a period when the 
patient is pregnant but the pregnancy test is negative and the menstrual 
history is of little use. However, the risks of 10 rad or less are extremely 
small during this period of gestation (all-or-none period,6 first 2 weeks). 
The patient will benefit from knowing that the diagnostic study was 
indicated and should be performed in spite of the fact that she may be 
pregnant. 
Scheduling the examination 
In those instances in which elective x-ray studies need to be scheduled, 
it is difficult to know whether to schedule them during the first half of 
the menstrual cycle just before ovulation or during the second half of the 
menstrual cycle. when most women will not be pregnant. The genetic 
risk of diagnostic exposures to the oocyte or the embryopathic effects on 
the preimplanted embryo is extremely small, and there are no data avail­
able to compare the relative risk of 10 rad to the oocyte or the preim­
planted embryo. If the diagnostic study is performed in the first 14 days 
of the menstrual cycle, should the patient be advised to defer conception 
for several months, based on the assumption that the deleterious effect of 
radiation to the ovaries decreases with increasing time between radiation 
exposure and a subsequent ovulation? The physician is in a quandary 
because he may be warning the patient about a very-lOW-risk pheno­
menon. On the other hand, aVOiding conception for several months is 
not an insurmountable hardship. This potential genetic hazard is quite 
- .-----------­
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speculative for man, as indicated by the report by the NCRP and BEIR 
committee report dealing with preconception radiation:3,B 
It is not known whether the interval between irradiation of the gonads and con­
ception has a marked effect on the frequency of genetic changes in human off­
spring, as has been demonstrated in the female mouse. Nevenheless, it may be 
advised for patients receiving high doses to the gonads (>25 rad, O.25Gy) to wait 
for several months after such exposures before conceiving additional offspring.3 
Because the patients exposed during diagnostic radiological procedures 
absorb considerably less than 25 rad, the recommendations made here 
may be unnecessary, but it involves no hardship to the patient or physi­
cian. Because both the NCRP and ICRP have previously recommended that 
elective radiological examinations of the abdomen and pelvis be perlormed 
during the first part of the menstrual cycle (lO-day rule, 14-day cycle) to 
protect the zygote from possible but largely conjectural hazards, the recom­
mendation to avoid fertilization of recently irradiated ova perhaps merits 
equal attention. 
Importance of determining pregnancy status of patient 
If exposures <10 rad do not measurably affect the exposed embryos, and 
it is recommended that diagnostic procedures should be perlormed at 
any time during the menstrual cycle, if necessary, for the medical care of 
the patient, why expend energy to determine the pregnancy status of the 
patient? 
There are several reasons why the physician and patient should share the 
burden of determining the pregnancy status before perlorming an x-ray or 
nuclear medicine procedure that exposes the uterus: 
1 If the physician is forced to include the possibility of pregnancy in the dif­
ferential diagnosis, a small percentage of diagnostic studies may no longer 
be considered necessary. Early symptoms of pregnancy may mimic certain 
types of gastrointestinal or genitourinary disease. 
2 	If the physician and patient are both aware that pregnancy is a possibility 
and the procedure is still perlormed, it is much less likely that the patient' 
will be upset if she subsequently proves to be pregnant. 
3 The careful evaluation of the reproductive status of women undergoing 
diagnostic procedures will prevent many unnecessary lawsuits. Many 
lawsuits are stimulated by the factor of surprise. In some instances, 
the jury is not concerned with cause and effect but with the fact that 
something was not done properly by the physicians. 17,18 In this day 
and age, failure to communicate adequately can be interpreted as less­
than-adequate medical care. Both these factors are eliminated if the 
patient's pregnancy status has been evaluated properly and the situ­
ation discussed adequately with the patient. Physicians are going to 
have to learn that practicing good technical medicine may not be good 
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enough in a litigation-prone society. Even more important, the patient 
will have more confidence if the decision to continue the pregnancy 
is made before the medical x-ray procedure is performed, because the 
necessity of performing the procedure would have been determined 
with the knowledge that the patient was pregnant. 
In every consultation dealing with the exposure of the embryo to diagnostic 
studies involving ionizing radiation (x-ray, CT scans, use of radionuclides) in 
which her reproductive risks or developmental risks for her fetus have not 
been increased by the radiation exposure, the patient should be informed 
that every healthy woman with a negative personal and genetic family 
reproductive history has background reproductive risks which are 3% for 
birth defects and 15% for miscarriage. We cannot change these background 
risks, which every woman faces. 
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